Relevance of Behavioral Research in the Evolving State of Anti-obesity Medications: Is the Glass Half Empty or Half Full?

  • Published In: Annals of Behavioral Medicine, 2024, v. 58, n. 7. P. 474 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Martin, Michelle Y; Rogers, Renee J 3 of 3

Abstract

Obesity continues to be a significant public health challenge. While weight loss medications have been studied and available for several years, the newest generation of highly effective anti-obesity medications (AOMs) will shift how behavioral science professionals approach obesity treatment and research. With the unique skill set of behavioral science professionals, this commentary suggests ways to integrate behavioral science into the rapidly evolving landscape of AOM use to accelerate better obesity care and generate new lines of research. The goal of this commentary is to stimulate discussion and encourage responsive and relevant action to improve population health. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Annals of Behavioral Medicine. 2024/07, Vol. 58, Issue 7, p474
  • Document Type:Article
  • Subject Area:Social Sciences and Humanities
  • Publication Date:2024
  • ISSN:0883-6612
  • DOI:10.1093/abm/kaae022
  • Accession Number:177947524
  • Copyright Statement:Copyright of Annals of Behavioral Medicine is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.